COA for AOD9604

Product Description
AOD9604 is a peptide fragment of the C-terminus of (Tyr177-191) to which a tyrosine is added at the N-terminus. Studies have suggested that AOD9604 is more effective than its predecessor AOD-9401 in its ability to stimulate lipolytic and anti-lipogenic activity. AOD9604 stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (prevents the transformation of fatty food materials into body fat) both in laboratory testing and in animals. In laboratory tests on fat cells from rodents, the  fragment released fat specifically from obese fat cells and reduced new fat accumulation in all fat cells.

Product Function
Aod9604 has the effect of stimulating the metabolism of fat cells. Obese patients lack HGH, but the results of clinical studies on its use for weight loss can lead to adverse reactions such as insuli n resistance and glucose tolerance.
A phase II clinical study of AOD9604, a new synthetic peptide drug derived from the carbon-terminal fragment of HGH, showed that it has the effect of HGH to stimulate fat cell metabolism, but has no adverse reactions, and can effectively reduce the weight of obese patients.